Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.

× No keyword cloud information.

5 in total

1. Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Am J Ophthalmol Date: 2016-06-04 Impact factor: 5.258

Review 2. Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.

Authors: M Ashraf; A Souka; R Adelman; S H Forster
Journal: Eye (Lond) Date: 2016-08-26 Impact factor: 3.775

3. Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab.

Authors: Edward H Wood; Peter A Karth; Darius M Moshfeghi; Theodore Leng
Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2015-10 Impact factor: 1.300

4. Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema.

Authors: Ehsan Rahimy; Abtin Shahlaee; M Ali Khan; Gui-Shuang Ying; Joseph I Maguire; Allen C Ho; Carl D Regillo; Jason Hsu
Journal: Am J Ophthalmol Date: 2015-12-31 Impact factor: 5.258

5. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis).

Authors: Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal: Am J Ophthalmol Date: 2009-05-09 Impact factor: 5.258

5 in total

1 in total

1. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

Authors: Dan Călugăru; Mihai Călugăru
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-01-20 Impact factor: 3.117

1 in total